These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11244594)

  • 1. [Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The south Lyon hospital center experience].
    Bobin JY; Spirito C; Isaac S; Zinzindohoue C; Joualee A; Khaled M; Perrin-Fayolle O
    Ann Chir; 2000 Nov; 125(9):861-70. PubMed ID: 11244594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
    Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
    J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
    Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
    Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
    Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
    Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
    Noguchi M
    J Surg Oncol; 2001 Feb; 76(2):144-56. PubMed ID: 11223844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
    Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
    Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
    Tuttle TM
    Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer.
    Chao C
    Am Surg; 2004 May; 70(5):414-9. PubMed ID: 15156949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer.
    Hung WK; Chan CM; Ying M; Chong SF; Mak KL; Yip AW
    Br J Surg; 2005 Dec; 92(12):1494-7. PubMed ID: 16308853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
    Chung MH; Ye W; Giuliano AE
    Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.